日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Macular Edema Ranibizumab versus Intravitreal Anti-inflammatory Therapy Trial: 24-Week Outcomes of Uveitic Macular Edema Re-treatment.

黄斑水肿雷珠单抗与玻璃体内抗炎治疗试验:葡萄膜炎性黄斑水肿再治疗的 24 周结果

Gonzales John, Acharya Nisha R, Sugar Elizabeth A, Burke Alyce E, Vitale Albert T, Gupta Vishali, Dunn James P, Lightman Susan L, Thorne Jennifer E, Kim Rosa Y, Yeh Steven, Altaweel Michael M, Kempen John H, Holbrook Janet T, Jabs Douglas A

Factors Predicting Visual Acuity Outcome in Intermediate, Posterior, and Panuveitis: The Multicenter Uveitis Steroid Treatment (MUST) Trial

影响中后葡萄膜炎和全葡萄膜炎患者视力预后的因素:多中心葡萄膜炎类固醇治疗(MUST)试验

Kempen, John H; Van Natta, Mark L; Altaweel, Michael M; Dunn, James P; Jabs, Douglas A; Lightman, Susan L; Thorne, Jennifer E; Holbrook, Janet T

Inflammation in retinal disease

视网膜疾病中的炎症

Whitcup, Scott M; Nussenblatt, Robert B; Lightman, Susan L; Hollander, David A

The impact of macular edema on visual function in intermediate, posterior, and panuveitis

黄斑水肿对中间葡萄膜炎、后葡萄膜炎和全葡萄膜炎患者视觉功能的影响

Taylor, Simon R J; Lightman, Susan L; Sugar, Elizabeth A; Jaffe, Glen J; Freeman, William R; Altaweel, Michael M; Kozak, Igor; Holbrook, Janet T; Jabs, Douglas A; Kempen, John H

Cytokines and chemokines in uveitis: is there a correlation with clinical phenotype?

葡萄膜炎中的细胞因子和趋化因子:与临床表型有相关性吗?

Ooi, Kenneth G-J; Galatowicz, Grazyna; Calder, Virginia L; Lightman, Susan L